Not even one year after becoming a commercial biotech, Krystal Biotech has blockbuster dreams for its flagship product.  | In ...
BMS is plotting a $400-million SDP investment at its Dublin 15 Cruiserath campus in Ireland, which will be used to crank out ...
Amgen is now open for business in Central Ohio after cutting the ribbon at its “most advanced facility to date.” Dubbed ...
The recently launched mega-agency VML has installed the creative leadership team for its health unit, appointing three VMLY&R ...
The chilling wind of the biotech winter has apparently spared BeiGene. While layoffs have been commonplace in the industry, ...
Chris Weber is bringing his three decades of healthcare agency experience to CG Life as the firm’s new senior vice president ...
For the third straight year, Sanofi CEO Paul Hudson has seen a slight dip in his compensation. For 2023, Hudson will receive ...
WE Communications has poached Avant Healthcare’s chief science and executive officer Arun Divakaruni, Ph.D. In his new role ...
Teva and Alvotech have braved a long and winding road on the quest to win approval for their biosimilar to AbbVie’s Humira. | ...
AstraZeneca, having surpassed its long-term $45 billion revenue goal last year, has handsomely rewarded its chief executive.
Following the exodus of several prominent drugmakers and some surprising drug pricing setbacks in Washington, the influential ...
Sanofi and Regeneron are investigating another COPD candidate, itepekimab, for former smokers, which make up roughly 70% of ...